Beloqui O - Search Results

1

Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?

Páramo JA, Rodríguez JA, Beloqui O, Orbe J. Páramo JA, et al. Among authors: beloqui o. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug;5(4):303-11. doi: 10.2174/1568006054553381. Curr Drug Targets Cardiovasc Haematol Disord. 2005. PMID: 16101563 Review.

2

Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

Beloqui O, Páramo JA, Orbe J, Benito A, Colina I, Monasterio A, Díez J. Beloqui O, et al. Eur Heart J. 2005 Jan;26(2):153-8. doi: 10.1093/eurheartj/ehi016. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15618071

3

[Cyclooxygenase-2: a new therapeutic target in atherosclerosis?].

Páramo JA, Beloqui O, Orbe J. Páramo JA, et al. Among authors: beloqui o. Med Clin (Barc). 2006 May 27;126(20):782-6. doi: 10.1157/13089104. Med Clin (Barc). 2006. PMID: 16792983 Review. Spanish.

4

Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects.

Páramo JA, Beloqui O, Colina I, Diez J, Orbe J. Páramo JA, et al. Among authors: beloqui o. J Thromb Haemost. 2005 Apr;3(4):662-4. doi: 10.1111/j.1538-7836.2005.01305.x. J Thromb Haemost. 2005. PMID: 15842351 Free article.

5

Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.

Orbe J, Beloqui O, Rodriguez JA, Belzunce MS, Roncal C, Páramo JA. Orbe J, et al. Among authors: beloqui o. Clin Chim Acta. 2006 Jun;368(1-2):138-43. doi: 10.1016/j.cca.2005.12.019. Epub 2006 Feb 3. Clin Chim Acta. 2006. PMID: 16458279 Free article.

6

Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects.

Martínez-Vila E, Páramo JA, Beloqui O, Orbe J, Irimia P, Colina I, Monreal I, Benito A, Barba J, Zubieta JL, Diez J. Martínez-Vila E, et al. Among authors: beloqui o. Cerebrovasc Dis. 2003;16(4):356-62. doi: 10.1159/000072557. Cerebrovasc Dis. 2003. PMID: 13130176

7

Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease.

Páramo JA, Beloqui O, Roncal C, Benito A, Orbe J. Páramo JA, et al. Among authors: beloqui o. Haematologica. 2004 Oct;89(10):1226-31. Haematologica. 2004. PMID: 15477208

8

C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.

Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodríguez JA, Díez J, Libby P, Páramo JA. Montero I, et al. Among authors: beloqui o. J Am Coll Cardiol. 2006 Apr 4;47(7):1369-78. doi: 10.1016/j.jacc.2005.10.070. Epub 2006 Mar 20. J Am Coll Cardiol. 2006. PMID: 16580524 Free article.

9

Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.

Zalba G, Fortuño A, Orbe J, San José G, Moreno MU, Belzunce M, Rodríguez JA, Beloqui O, Páramo JA, Díez J. Zalba G, et al. Among authors: beloqui o. Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):587-93. doi: 10.1161/01.ATV.0000256467.25384.c6. Epub 2006 Dec 28. Arterioscler Thromb Vasc Biol. 2007. PMID: 17194891 Free article.

10

[Association of age, inflammatory markers and subclinical atherosclerosis in subjects free from cardiovascular disease].

Páramo JA, Orbe J, Beloqui O, Colina I, Benito A, Rodríguez JA, Díez J. Páramo JA, et al. Among authors: beloqui o. Med Clin (Barc). 2008 Sep 27;131(10):361-6. doi: 10.1016/s0025-7753(08)72283-8. Med Clin (Barc). 2008. PMID: 18842208 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters